Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Tobacco Dependence
Interventions
DRUG

Varenicline

Standard dosing: 0.5 mg/day on days 1-3, 0.5 mg twice daily (morning, evening) on days 4-7, then 1 mg twice daily to the end of the medication period.

DRUG

Placebo

Dosing schedule matched to active comparator: on tablet on days 1-3, one tablet twice daily (morning, evening) on days 4-7, then one tablet twice daily to the end of the medication period.

Trial Locations (1)

02912

Brown University, 121 South Main Street, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Brown University

OTHER